Urgency-frequency Syndrome
11
2
2
6
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
18.2%
2 terminated out of 11 trials
75.0%
-11.5% vs benchmark
0%
0 trials in Phase 3/4
17%
1 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (11)
rTMS in Overactive Bladder
Fluoroscopy Radiation Reduction During Sacral Neuromodulation Lead Placement
Percutaneous Nerve Evaluation Trial Time
TEST-ON - Does iStim Reduce Urinary Urgency?
OAB and the Microbiome
Efficacy of Li-SWT on Persistent Storage Symptoms After Transurethral Surgery for BPO
The Effect of Solifenacin Used for Lower Urinary Tract Symptoms on Sexual Function
InterStim Basic Evaluation Lead Post-Market Clinical Follow-up Study
Sensitivity of Extended Cultures in Diagnosing Urinary Tract Infections
Comparison of Electrical Pudendal Nerve Stimulation and Tolterodine Tartrate for Urgency-Frequency Syndrome in Women
The Long-term Efficacy of Electrical Pudendal Nerve Stimulation for the Urgency-Frequency Syndrome in Women